Showing 126–136 of 136 · North America
FY2026 revenue $3.20bn (+16.3%); operating margin 28.7%; net income $908.9m.
No debt; $6.56bn cash and short-term investments.
Listed (MDRX).
Latest full-year results not yet captured by HSH.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $1.10bn (+17.0%); operating margin 22.7%; net income $112.1m.
Balance sheet figures not captured from release.
FY2025 revenue C$1.40bn (+52.2%); net income C$4.5m.
Revenue +52%; total net income C$4.5m. Attributable result not captured.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue $9.55bn (+13.1%); operating margin 7.5%; net income $693.0m.
Cash $5.44bn; debt $2.99bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $8.23bn (+7.2%); operating margin 13.3%; net income $705.1m.
Cash $591.9m; debt $7.52bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.